Wellbutrin: A Clinically Proven Antidepressant for Major Depressive Disorder
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.22 | $66.49 (0%) | 🛒 Add to cart |
| 60 | $1.96 | $132.99 $117.87 (11%) | 🛒 Add to cart |
| 90 | $1.88 | $199.48 $169.26 (15%) | 🛒 Add to cart |
| 120 | $1.84 | $265.97 $220.64 (17%) | 🛒 Add to cart |
| 180 | $1.80 | $398.96 $323.40 (19%) | 🛒 Add to cart |
| 270 | $1.77 | $598.44 $477.54 (20%) | 🛒 Add to cart |
| 360 | $1.75
Best per pill | $797.92 $631.69 (21%) | 🛒 Add to cart |
Wellbutrin (bupropion hydrochloride) is an atypical antidepressant medication indicated for the treatment of major depressive disorder (MDD) and seasonal affective disorder (SAD). As a norepinephrine-dopamine reuptake inhibitor (NDRI), it functions distinctly from SSRIs and SNRIs, offering a unique therapeutic profile. Its mechanism provides effective symptom relief with a differentiated side effect spectrum, making it a valuable option in psychopharmacological management.
Features
- Active ingredient: Bupropion hydrochloride
- Available in immediate-release (75 mg, 100 mg), sustained-release (100 mg, 150 mg, 200 mg), and extended-release (150 mg, 300 mg) formulations
- NDRI mechanism: Inhibits reuptake of norepinephrine and dopamine
- Non-serotonergic action, reducing risk of certain adverse effects common to other antidepressants
- FDA-approved for MDD, SAD, and as an aid to smoking cessation treatment (under the brand name Zyban)
Benefits
- Effective reduction of depressive symptoms, including low mood, anhedonia, and fatigue
- Lower incidence of sexual dysfunction and weight gain compared to SSRIs
- May improve focus, energy, and motivation due to its dopaminergic activity
- Does not typically cause sedation, making it suitable for daytime use
- Can be used as augmentation therapy in partial responders to other antidepressants
Common use
Wellbutrin is primarily prescribed for the management of major depressive disorder in adults. It is also indicated for preventing episodes of seasonal affective disorder and is widely used off-label for attention-deficit/hyperactivity disorder (ADHD), bipolar depression (with mood stabilizer), and as smoking cessation aid. Its activating properties make it particularly useful for patients experiencing significant fatigue or apathy as part of their depressive symptomatology.
Dosage and direction
Dosage must be individualized based on clinical response and tolerance. The typical starting dose for Wellbutrin SR is 150 mg once daily in the morning, which may be increased to 150 mg twice daily after at least 3 days. The maximum recommended dose is 400 mg per day, given as 200 mg twice daily. For Wellbutrin XL, the initial dose is 150 mg once daily, which may be increased to 300 mg once daily after several days. Doses should be administered at least 8 hours apart for SR formulation and taken whole, without crushing, chewing, or dividing. Dosage adjustments are necessary in patients with hepatic impairment.
Precautions
Patients should be monitored for emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, and mania. Use with caution in patients with a history of seizure disorder, cranial trauma, or conditions predisposing to seizures. May elevate blood pressure; regular monitoring recommended. Use cautiously in patients with hepatic or renal impairment. Abrupt discontinuation should generally be avoided.
Contraindications
Wellbutrin is contraindicated in patients with seizure disorder or history of seizures. Contraindicated in patients with current or prior diagnosis of bulimia or anorexia nervosa due to increased seizure risk. Should not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI treatment. Hypersensitivity to bupropion or any component of the formulation is an absolute contraindication.
Possible side effect
Common adverse reactions include dry mouth (up to 28%), nausea (up to 23%), insomnia (up to 22%), headache (up to 26%), and dizziness (up to 22%). Less frequently, patients may experience tremor, excessive sweating, blurred vision, tachycardia, constipation, and weight loss. The most serious potential adverse effects include seizures (approximately 0.4% at 300-450 mg/day), hypertensive episodes, and psychiatric symptoms including hallucinations and paranoia.
Drug interaction
Concomitant use with MAOIs is contraindicated due to risk of hypertensive crisis. May lower seizure threshold; use cautiously with other medications that lower seizure threshold. May interact with drugs metabolized by CYP2D6 isoenzyme (e.g., certain antidepressants, antipsychotics, beta-blockers, and type 1C antiarrhythmics). Caution advised with drugs that affect dopamine levels. Alcohol consumption should be minimized or avoided due to increased seizure risk.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is close to the time for the next dose, the missed dose should be skipped. Patients should never take double or extra doses to make up for a missed dose. For twice-daily formulations, doses should not be taken within 8 hours of each other.
Overdose
Overdose may lead to seizures, hallucinations, loss of consciousness, sinus tachycardia, and cardiac conduction disturbances. Fatal outcomes have been reported with massive overdoses. Symptoms generally appear within 4-8 hours post-ingestion. Management includes ECG monitoring for at least 48 hours, supportive care, and seizure control with benzodiazepines. There is no specific antidote; gastric lavage may be considered if presentation is early.
Storage
Store at room temperature (20-25°C or 68-77°F), with excursions permitted between 15-30°C (59-86°F). Keep in original container, tightly closed, and protect from light and moisture. Keep out of reach of children and pets. Do not store in bathroom or other humid areas. Dispose of unused medication properly according to local regulations.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Wellbutrin is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary. Patients should not alter their dosage or treatment regimen without consulting their physician. The full prescribing information should be consulted before initiating therapy.
Reviews
Clinical studies demonstrate Wellbutrin’s efficacy in major depressive disorder, with response rates comparable to other antidepressants. Many patients report particular benefit regarding energy levels and minimal sexual side effects. However, individual experiences vary significantly. Some patients find the activating properties too stimulating, while others appreciate the absence of sedation. The unique NDRI mechanism continues to make it a valuable option in the antidepressant arsenal, particularly for patients who cannot tolerate SSRI side effects or require additional focus and motivation support.